Sponsor or institution
Clinical trials and research at Rznomics, Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Rznomics, Inc. that are recruiting, in South Korea. By phase: Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Evaluating RZ-001 with Valganciclovir and Atezolizumab/Bevacizumab for Liver Cancer
This study is testing a new combination treatment for advanced liver cancer to see if it is safe and effective for patients with a specific type of the disease.
-
Evaluating RZ-001 with Valganciclovir for Glioblastoma
This study is testing a new treatment combining RZ-001 and Valganciclovir to see if it can help people with a specific type of brain cancer called glioblastoma.
Quick answers
How many clinical trials run by Rznomics, Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in South Korea. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.